{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:53:11Z","timestamp":1791337991216,"version":"4.3.1"},"reference-count":49,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Associazione Italiana per lo Studio delle Patologie Endocrine Rare"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Patients affected by the classic form of congenital adrenal hyperplasia (CAH) need lifelong glucocorticoid (GC) therapy. GC represents one of the primary causes of secondary osteoporosis; however, the effect of steroid therapy on bone mineral density (BMD) in patients with CAH is still controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate and compare the BMD of a group of prepubertal patients and a subgroup of young adult patients with CAH receiving chronic GC therapy, with healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A referral center for pediatric endocrinology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Healthy Controls<\/jats:title>\n                    <jats:p>Fifty-six prepubertal children with CAH treated with GC from diagnosis and 60 prepubertal healthy children of comparable age. A subgroup of 36 young patients was studied after the completion of puberty, and their BMD was compared to that of 51 young adult healthy volunteers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BMD was measured in the lumbar spine and in the whole body by dual-energy x-ray absorptiometry. Multivariate models were used for the comparison of BMD measurements between patients and control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Whole-body BMD measurements of patients were significantly lower compared with healthy controls, both in boys and in girls. No differences were found in lumbar spine measurements. BMD expressed as Z-score decreased markedly in CAH patients from prepuberty to adulthood, particularly in young adult males. Men with CAH showed lumbar spine BMD values significantly lower than control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Boys and young adult men with classic form of CAH have lower BMD values compared with healthy controls. This may put them at risk of developing osteoporosis early in life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf123","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:20:31Z","timestamp":1740151231000},"page":"e3850-e3856","source":"Crossref","is-referenced-by-count":8,"title":["Bone Mineral Density in Patients With Congenital Adrenal Hyperplasia From Prepubertal to Adult Age"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6506-5505","authenticated-orcid":false,"given":"Marianna Rita","family":"Stancampiano","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pitea","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-6673","authenticated-orcid":false,"given":"Katia","family":"Maruca","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]},{"name":"Laboratory of Pediatric Endocrinology, Department of Pediatrics, IRCCS San Raffaele Hospital , 20132 Milano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Laura Carla","family":"Meroni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Bucolo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-6715","authenticated-orcid":false,"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Endo-ERN Center for Rare Endocrine Diseases, IRCCS San Raffaele Hospital , 20132 Milan ,","place":["Italy"]},{"name":"Laboratory of Pediatric Endocrinology, Department of Pediatrics, IRCCS San Raffaele Hospital , 20132 Milano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"10372","key":"2025101519573378000_dgaf123-B1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","article-title":"Congenital adrenal hyperplasia","volume":"401","author":"Auer","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"2025101519573378000_dgaf123-B2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2018-02629","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"104","author":"Speiser","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025101519573378000_dgaf123-B3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2025101519573378000_dgaf123-B4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-005-0017-7","article-title":"Mechanisms of glucocorticoid action in bone","volume":"3","author":"Canalis","year":"2005","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2025101519573378000_dgaf123-B5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/jbmr.1997.12.3.464","article-title":"Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro","volume":"12","author":"Kasperk","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025101519573378000_dgaf123-B6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.12507","article-title":"Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"82","author":"El-Maouche","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2025101519573378000_dgaf123-B7","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia","volume":"82","author":"Girgis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101519573378000_dgaf123-B8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/JPEM.2007.20.2.227","article-title":"Bone mineral status in children with congenital adrenal hyperplasia","volume":"20","author":"Fleischman","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"2025101519573378000_dgaf123-B9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia","volume":"45","author":"Guo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2025101519573378000_dgaf123-B10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/8756-3282(96)00003-8","article-title":"Bone density in young patients with congenital adrenal hyperplasia","volume":"18","author":"Mora","year":"1996","journal-title":"Bone"},{"issue":"3","key":"2025101519573378000_dgaf123-B11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101519573378000_dgaf123-B12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia","volume":"100","author":"Gussiny\u00e9","year":"1997","journal-title":"Pediatrics"},{"issue":"11","key":"2025101519573378000_dgaf123-B13","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101519573378000_dgaf123-B14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2265.2008.03518.x","article-title":"Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy","volume":"71","author":"Zimmermann","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2025101519573378000_dgaf123-B15","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101519573378000_dgaf123-B16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/EJE-16-0104","article-title":"Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"175","author":"Ceccato","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025101519573378000_dgaf123-B17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cen.14149","article-title":"Bone mineral density and fractures in congenital adrenal hyperplasia: findings from the dsd-LIFE study","volume":"92","author":"Riehl","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1-2","key":"2025101519573378000_dgaf123-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000515833","article-title":"Bone mass in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"94","author":"Espinosa Reyes","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"2025101519573378000_dgaf123-B19","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025101519573378000_dgaf123-B20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025101519573378000_dgaf123-B21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101519573378000_dgaf123-B22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-12-0196","article-title":"Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency","volume":"167","author":"Nermoen","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2025101519573378000_dgaf123-B23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fendo.2020.00493","article-title":"Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"11","author":"Rangaswamaiah","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2025101519573378000_dgaf123-B24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)","volume":"29","author":"Cacciari","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2025101519573378000_dgaf123-B25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"issue":"2","key":"2025101519573378000_dgaf123-B26","first-page":"335","article-title":"Radiographic atlas of skeletal development of the hand and wrist","volume":"108","author":"Greulich","year":"1950","journal-title":"Anat Rec"},{"issue":"1","key":"2025101519573378000_dgaf123-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-2918(04)90001-X","article-title":"Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis","volume":"26","author":"Boling","year":"2004","journal-title":"Clin Ther"},{"issue":"1","key":"2025101519573378000_dgaf123-B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"2025101519573378000_dgaf123-B29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","article-title":"Novel strategies for hydrocortisone replacement","volume":"23","author":"Debono","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2025101519573378000_dgaf123-B30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MED.0000000000000256","article-title":"Novel treatment strategies in congenital adrenal hyperplasia","volume":"23","author":"Turcu","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"2025101519573378000_dgaf123-B31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000522260","article-title":"Current and novel treatment strategies in children with congenital adrenal hyperplasia","volume":"96","author":"Nordenstr\u00f6m","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"2025101519573378000_dgaf123-B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-012286551-0\/50014-2","volume-title":"Pediatric Bone","author":"Mora","year":"2003"},{"issue":"4","key":"2025101519573378000_dgaf123-B33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.beem.2018.06.002","article-title":"Update on bone density measurements and their interpretation in children and adolescents","volume":"32","author":"Di Iorgi","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2025101519573378000_dgaf123-B34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11657-020-00755-y","article-title":"DHEA in bone: the role in osteoporosis and fracture healing","volume":"15","author":"Kirby","year":"2020","journal-title":"Arch Osteoporos"},{"issue":"5","key":"2025101519573378000_dgaf123-B35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-007-0520-z","article-title":"Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial","volume":"19","author":"von M\u00fchlen","year":"2008","journal-title":"Osteoporos Int"},{"issue":"6","key":"2025101519573378000_dgaf123-B36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/EJE-07-0887","article-title":"Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency","volume":"158","author":"Chakhtoura","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2025101519573378000_dgaf123-B37","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.jsbmb.2020.105734","article-title":"Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency","volume":"204","author":"Auer","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2025101519573378000_dgaf123-B38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11657-022-01090-0","article-title":"Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency","volume":"17","author":"Lee","year":"2022","journal-title":"Arch Osteoporos"},{"issue":"3","key":"2025101519573378000_dgaf123-B39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2003-0003","article-title":"Androgens and bone","volume":"25","author":"Vanderschueren","year":"2004","journal-title":"Endocr Rev"},{"issue":"6","key":"2025101519573378000_dgaf123-B40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s002239900369","article-title":"Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations","volume":"61","author":"Kasperk","year":"1997","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2025101519573378000_dgaf123-B41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cen.14967","article-title":"Long-term health consequences of congenital adrenal hyperplasia","volume":"101","author":"Pofi","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2025101519573378000_dgaf123-B42","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1210\/jc.2014-4124","article-title":"Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French National Survey","volume":"100","author":"Bouvattier","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025101519573378000_dgaf123-B43","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","article-title":"High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia","volume":"86","author":"Stikkelbroeck","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025101519573378000_dgaf123-B44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mce.2015.01.039","article-title":"Management considerations for the adult with congenital adrenal hyperplasia","volume":"408","author":"Auchus","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2025101519573378000_dgaf123-B45","first-page":"4602129","article-title":"Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2025101519573378000_dgaf123-B46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1385\/JCD:7:3:334","article-title":"Bone mineral density in early-onset hypogonadism and the effect of hormonal replacement","volume":"7","author":"Vieira da Costa","year":"2004","journal-title":"J Clin Densitom"},{"issue":"7","key":"2025101519573378000_dgaf123-B47","first-page":"2238","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia","volume":"80","author":"Cameron","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025101519573378000_dgaf123-B48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency","volume":"45","author":"J\u00e4\u00e4skel\u00e4inen","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2025101519573378000_dgaf123-B49","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1210\/jc.2005-2823","article-title":"Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency","volume":"91","author":"Sciannamblo","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf123\/62165679\/dgaf123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3850\/62165679\/dgaf123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3850\/62165679\/dgaf123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:57:46Z","timestamp":1760572666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/11\/e3850\/8042006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf123","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,2,25]]}}}